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INTRODUCTION
Glycogen-rich carcinoma (GRC) is a rare special
histologic subtype of breast cancer, comprising 1.4%
of breast malignancies(1). The clear cytoplasm
observed in histological specimens is caused by the
extraction of water-soluble glycogen during histological
processing. We reviewed the cytological findings
in two cases, which were histologically diagnosed
by surgically resected specimens.
CASE REPORT
Case 1 : A 59-year old woman had complained of
a bloody nipple discharge and a palpable mass in
her right breast for three months. Case 2 : A 53-
year old woman had noticed a mass in her left
breast, and the tumor had gradually enlarged. They
visited Tokushima Breast Care Clinic and received
ultrasonography and mammography. Fine-needle
aspiration biopsy cytology (FNABC) revealed malig-
nant cells from their lesions. A mastectomy with axil-
lary dissection was performed at another institution.
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CYTOLOGICAL FINDINGS
On a hemorrhagic background, small clusters of
atypical cells were identified in both cases. The
tumor cells had a high N/C ratio and large and
polygonal nuclei with prominent nucleoli (Figs. 1A-
1D). A moderate amount of eosinophilic, finely
granular cytoplasm was observed in most of the
tumor cells. However, some were rich in foamy and
vacuolated cytoplasm. Mitotic figures were infrequent.
MACROSCOPIC FINDINGS
The tumor of Case 1 consisted of many solid and
whitish yellow nodules measuring a maximum of
1cm. Some nodules were noted to extend into the
surrounding adipose tissue. The gross findings of
Case 2 did not differ from those of the usual invasive
carcinoma of the breast. The tumor measured 2.5×
2.3×2.0 cm, a whitish-yellow solitary mass with
irregular margins. Necrosis, bleeding and infarction
were not prominent in either case.
HISTOLOGICAL AND IMMUNOHISTOCHEMICAL
FINDINGS
The following stains and immunohistochemical
examinations were performed : hematoxylin and
eosin (HE), periodic acid-Schiff (PAS) with and with-
out diastase pretreatment, alcian blue, mucicarmine ;
Cam 5.2 (cytokeratin) (BECTON, prediluted) , AE1/
AE3 (cytokeratin) (DAKO ×50), epithelial mem-
brane antigen (EMA) (clone : E 29 ; DAKO, ×100),
desmin (DAKO, ×50), vimentin (DAKO, ×150),
carcinoembryonic antigen (CEA) (polyclonal ; DAKO,
×50), estrogen receptor (DAKO, ×50) and c-erbB-2
(clone : AO485 ; DAKO, ×800). Immunohistochemical
staining was carried out with DAKO LSAB kit.
The tumor cells of both cases had mostly clear and
granular cytoplasm, small and hyperchromatic nuclei
and prominent nucleoli (Figs. 1E-1G). The cyto-
plasmic granular staining by PAS was abolished
by pretreatment with diastase. The tumors showed
both intraductal and invasive growth patterns. Al-
though a comedo pattern was evident in both cases,
no cribriform pattern was observed in either of the
cases. Alcian blue and mucicarmine failed to show
mucus in the tumor cells in either case. The tumor
had four and seventy mitotic figures per 10 high
power fields (HPFs) in Cases 1 and 2, respectively.
Immunohistochemically, the tumor cells in both
cases were positive for Cam 5.2, AE 1/AE 3, but
negative for vimentin, desmin and estrogen receptor.
CEA was weakly positive in Case 1, but negative in
Case2. Faint or barely perceptible membrane staining
of c-erbB-2 in more than 10% of the tumor cells was
observed in both cases (Fig. 1H).
DISCUSSION
GRC of the breast, a rare histologic subtype
originally reported by Hull et al . in 1981, is defined
when 90% or more tumor cells have clear cytoplasm
containing glycogen in histological specimens (2-
4). Histologically, our cases were consistent with
the difinition. In the records of Tokushima Breast
Care Clinic, between 1996 and 2001, two of 217
(0.9 percent) cases of breast carcinoma were GRC.
Although rare, the cytologic findings of GRC
have been described in a few case reports. Satoh
et al . reported that tumor cells with various nuclear
atypia, small round or ovoid nuclei and abundant,
clear cytoplasm were identified in FNABC(4). Borislav
et al . reported that papillary cell groups and single
tall columnar cells with apical cytoplasmic projections
were contained in the aspirate(5). Although foamy
and vacuolated cytoplasm could be seen in some
tumor cells, we diagnosed both cases as ‘simple’
adenocarcinoma. With the PAS reaction, the accu-
mulation of glycogen may be easily demonstrated
by cytology. In our laboratory, routine cytological
screening of aspiration biopsies of the breast has
been performed only by standard Papanicolaou
staining.
The differential diagnosis of GRC includes mam-
mary carcinomas with clear or vacuolated cytoplasm,
and lipid rich carcinoma. The presence of lipid
cannot be demonstrated by cytology because aspi-
ration biopsy smears were immediately fixed in
95% ethanol. The presence of lipid can be demon-
strated in frozen sections of fresh tissue or electron
microscopy.
The prognosis of glycogen-rich carcinoma were
described in many reports. In the reported cases,
14 of 35 patients (forty percents) of invasive glycogen-
rich carcinomas died. Metastasis in the lymph
nodes were observed in 17 patients (49 percents).
The prognosis of glycogen-rich carcinoma were
reported to be worse(6). The patients of case 1
and 2 are now well and post-operative regular
checkup are necessary.
N. Satake et al. glycogen-rich carcinoma of the breast１９４
A B
C D
E F
G H
Figure 1 : Cytological and histological findings. A, B (Case 1), C, D (Case 2) : Aspiration cytology. In a hemorrhagic background,
tumor cells with polygonal nuclei and prominent nucleus were observed. Clear cytoplasm (arrow) was seen in some tumor cells. E
(Case 1) : The tumor was composed of solid alveolar proliferating clear cells. F (Case 2) : The tumor was composed of solid alveolar
proliferating granular cells. G (Case 2) : The PAS reaction revealed abundant PAS-positive, diastase-digestible material in the
cytoplasm in both cases. H (Case 1) : The membrane of the tumor cells was weakly positive for c-erbB-2.
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The c-erbB-2 (HER2/neu) proto-oncogene encodes
a receptor protein with a tyrosine kinase domain
that shows extensive homology with epidermal
growth factor receptor (EGFR) (7, 8). HER 2/neu
proto-oncogene is amplified in 25 to 30% of primary
breast carcinomas(9) and HER 2/neu overexpression
is associated with a more aggressive potential and
shortened survival(10). As far as we know, the
immunohistochemical features of c-erbB-2 proto-
oncogene in GRC have not been reported.
Estrogen receptor (ER) plays an important role
in the biology of breast cancer and is accepted as a
good prognostic marker. Estrogen receptor was
positive in the case reported by Hull et al . (2) and
among four invasive carcinoma cases reported by
Hayes et al ., two cases were positive and the other
two were negative(11). The positive rate of ER in
15 cases reported by Fujino et al. was 53%(6).
However, the tumor cells were negative for ER in
our two cases.
In summary, it may be difficult to diagnose GRC
by FNABC, particularly when the cytological spec-
imens are processed promptly. Clear cell changes
caused by glycogen and other substances are often
observed histologically in ordinary intraductal and
invasive ductal carcinomas. Since there was a poorer
overall prognosis for GRC than for ordinary ductal
carcinoma and the prominent features could not be de-
tected by ultrasound examination and mammography,
diagnosing GRC in cytological specimens may be
of significance. In this concern, PAS reaction (with
or without diastase digestion) in addition to the
standard Papanicolaou stain may be necessary in
routine cytological screening of aspiration biopsies
of the breast.
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